Rigel Pharmaceuticals (NASDAQ: RIGL ) is a commercial-stage biotechnology company that is developing oral small-molecule kinase inhibitors, which are used to help treat blood disorders and certain cancers. Despite having three commercialized products and marginsMy career in the world of investing began at an early age, fueled by the potential for profits, I first began investing at the age of 11 with the help of my father. I first began picking stocks by looking at what was going to logically make money, an ...

Steven Jon Kaplan began TrueContrarian.com in August 1996 as a value-investing newsletter which since March 2020 has included two weekly 75-minute Zoom meetings. Steve provides long-term tax and investment planning. He has been trading since 1981 and handles separately managed accounts for qualified clients with a 20% performance fee on net profits and zero management fees. Steve has been quoted frequently by U.S. News and World Report, MarketWatch.com, and Barron's. Steve appeared on Market Watch cable TV ...